WAT Valuation Metrics
WAT Stock Price Metrics
WAT Dividend Metrics
WAT Growth Rate Metrics
WAT Discounted Cash Flow Metrics
| Fair Value Price | $235.02 |
| Margin of Safety | (35.76%) |
WAT Revenue Metrics
WAT PE Ratio Metrics
| PE Ratio | 46.49 |
| PE Ratio Avg TTM | 31.91 |
| PE Ratio Avg 3Y | 30.92 |
| Current VS TTM Avg | +45.68% |
| Current VS 3Y Avg | +50.35% |
| Current VS 5Y Avg | +52.79% |
WAT PS Ratio Metrics
| PS Ratio | 7.97 |
| PS Ratio Avg TTM | 6.60 |
| PS Ratio Avg 3Y | 6.58 |
| Current VS TTM Avg | +20.73% |
| Current VS 3Y Avg | +21.18% |
| Current VS 5Y Avg | +16.72% |
WAT PB Ratio Metrics
| PB Ratio | 1.97 |
| PB Ratio Avg TTM | 8.28 |
| PB Ratio Avg 3Y | 13.92 |
| Current VS TTM Avg | -76.19% |
| Current VS 3Y Avg | -85.85% |
| Current VS 5Y Avg | -93.91% |
WAT Price to Free Cash Flow Ratio Metrics
| PFCF Ratio | 113.83 |
| PFCF Ratio Avg TTM | 40.12 |
| PFCF Ratio Avg 3Y | 39.39 |
| Current VS TTM Avg | +183.70% |
| Current VS 3Y Avg | +188.97% |
| Current VS 5Y Avg | +196.46% |
WAT Debt to Equity Ratio Metrics
| Debt/Equity Ratio | 0.58 |
| Debt/Equity Ratio Avg TTM | 0.76 |
| Debt/Equity Ratio Avg 3Y | 1.73 |
| Current VS TTM Avg | -23.18% |
| Current VS 3Y Avg | -66.52% |
| Current VS 5Y Avg | -80.17% |
WAT PEG Ratio Metrics
| PEG Ratio | 75.62 |
| PEG Ratio Avg TTM | 75.62 |
| PEG Ratio Avg 3Y | 75.62 |
| Current VS TTM Avg | 0.00% |
| Current VS 3Y Avg | 0.00% |
| Current VS 5Y Avg | 0.00% |
WAT FCF Yield
| FCF Yield | 0.88% |
| FCF Yield Avg TTM | 2.83% |
| FCF Yield Avg 3Y | 2.68% |
| Current VS TTM Avg | -68.88% |
| Current VS 3Y Avg | -67.12% |
| Current VS 5Y Avg | -67.42% |
WAT Earnings Yield
| Earnings Yield | 2.15% |
| Earnings Yield Avg TTM | 3.21% |
| Earnings Yield Avg 3Y | 3.32% |
| Current VS TTM Avg | -32.99% |
| Current VS 3Y Avg | -35.20% |
| Current VS 5Y Avg | -36.07% |
WAT EV/EBIT Ratio Metrics
| Ev/Ebit Ratio | 54.60 |
| Ev/Ebit Ratio Avg TTM | 27.55 |
| Ev/Ebit Ratio Avg 3Y | 26.51 |
| Current VS TTM Avg | +98.18% |
| Current VS 3Y Avg | +105.99% |
| Current VS 5Y Avg | +108.10% |
WAT EV/EBITDA Ratio Metrics
| Ev/Ebitda Ratio | 38.03 |
| Ev/Ebitda Ratio Avg TTM | 21.59 |
| Ev/Ebitda Ratio Avg 3Y | 21.24 |
| Current VS TTM Avg | +76.11% |
| Current VS 3Y Avg | +79.06% |
| Current VS 5Y Avg | +77.26% |
WAT EV/Assets Ratio Metrics
| Ev/Assets Ratio | 1.43 |
| Ev/Assets Ratio Avg TTM | 4.12 |
| Ev/Assets Ratio Avg 3Y | 4.55 |
| Current VS TTM Avg | -65.33% |
| Current VS 3Y Avg | -68.58% |
| Current VS 5Y Avg | -73.86% |
WAT EV/Sales Ratio Metrics
| Ev/Sales Ratio | 9.32 |
| Ev/Sales Ratio Avg TTM | 7.03 |
| Ev/Sales Ratio Avg 3Y | 7.13 |
| Current VS TTM Avg | +32.59% |
| Current VS 3Y Avg | +30.74% |
| Current VS 5Y Avg | +27.27% |
WAT Current Ratio Metrics
| Current Ratio | 1.73 |
| Current Ratio Avg TTM | 1.92 |
| Current Ratio Avg 3Y | 2.08 |
| Current VS TTM Avg | -9.90% |
| Current VS 3Y Avg | -16.63% |
| Current VS 5Y Avg | -16.49% |
WAT Quick Ratio Metrics
| Quick Ratio | 1.27 |
| Quick Ratio Avg TTM | 1.39 |
| Quick Ratio Avg 3Y | 1.50 |
| Current VS TTM Avg | -8.63% |
| Current VS 3Y Avg | -15.47% |
| Current VS 5Y Avg | -17.53% |
WAT ROIC Metrics
| ROIC | 17.57% |
| ROIC Avg 3Y | 20.73% |
| ROIC Avg 5Y | 22.79% |
| Current VS 3Y Avg | -15.22% |
| Current VS 5Y Avg | -22.89% |
| Current VS 10Y Avg | -8.72% |
WAT Return on Assets Metrics
| ROA | 12.66 |
| ROA Avg TTM | 13.34 |
| ROA Avg 3Y | 15.53 |
| Current VS TTM Avg | -5.06% |
| Current VS 3Y Avg | -18.48% |
| Current VS 5Y Avg | -26.17% |
WAT Return on Equity Metrics
| ROE | 25.09 |
| ROE Avg TTM | 29.98 |
| ROE Avg 3Y | 64.02 |
| Current VS TTM Avg | -16.32% |
| Current VS 3Y Avg | -60.81% |
| Current VS 5Y Avg | -77.51% |
WAT Net Profit Margin Metrics
| Net Profit Margin | 20.30% |
| Net Profit Margin Avg TTM | 20.93% |
| Net Profit Margin Avg 3Y | 21.85% |
| Current VS TTM Avg | -3.01% |
| Current VS 3Y Avg | -7.08% |
| Current VS 5Y Avg | -9.31% |
Last Updated: Wednesday, June 10, 2026
About Waters Corporation
Waters Corporation is a global leader in specialized measurement, delivering analytical solutions across Asia, the Americas, and Europe. The company operates through two main divisions: Waters and TA. Under its Waters segment, it engineers, manufactures, sells, and provides support for high and ultra-performance liquid chromatography and mass spectrometry (MS) systems. This includes essential consumables like chromatography columns and comprehensive post-warranty service plans. The TA segment focuses on designing, producing, selling, and servicing instruments for thermal analysis, rheometry, and calorimetry. Additionally, Waters develops and supplies sophisticated software that integrates with both its own instruments and those from other manufacturers. The company's advanced MS technology plays a crucial role in various applications, such as drug discovery and development (including clinical trial assessments), analyzing proteins involved in disease processes, ensuring nutritional safety, and conducting environmental testing. Its thermal analysis, rheometry, and calorimetry instruments are vital for assessing the suitability and stability of a wide range of materials, including fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids. These instruments support diverse sectors like industrial manufacturing, consumer goods, healthcare products, and life science research. Waters' extensive client base spans the life sciences, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental sectors, where its products are instrumental in research and development, quality assurance, and general laboratory operations. Established in 1958, Waters Corporation is headquartered in Milford, Massachusetts.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Udit Batra